|
HS Code |
385249 |
| Generic Name | Ticarcillin Disodium |
| Chemical Formula | C15H14N2Na2O6S2 |
| Molecular Weight | 480.39 g/mol |
| Drug Class | Extended-spectrum penicillin antibiotic |
| Cas Number | 4697-14-7 |
| Appearance | White to off-white crystalline powder |
| Solubility | Freely soluble in water |
| Route Of Administration | Intravenous |
| Mechanism Of Action | Inhibits bacterial cell wall synthesis |
| Spectrum Of Activity | Primarily Gram-negative and some Gram-positive bacteria |
| Storage Temperature | 2°C to 8°C (refrigerated) |
| Primary Use | Treatment of moderate to severe infections |
As an accredited Ticarcillin Disodium factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Sterile white powder in a clear glass vial, sealed with a rubber stopper; labeled "Ticarcillin Disodium 3g," packaged individually. |
| Shipping | Ticarcillin Disodium is shipped in tightly sealed, moisture-resistant containers, protected from light and extreme temperatures. It is classified as non-hazardous for transport. Shipping is typically done via air or ground with appropriate labeling, and all handling follows standard protocols for pharmaceutical chemicals to ensure product integrity and safety during transit. |
| Storage | Ticarcillin Disodium should be stored in a tightly sealed container, protected from light, moisture, and excessive heat. Store at 2°C to 8°C (36°F to 46°F) in a refrigerator. Do not freeze. Keep away from incompatible substances such as strong oxidizers. Ensure the storage area is well-ventilated and limit access to authorized personnel only. |
|
Purity 98%: Ticarcillin Disodium with a purity of 98% is used in bacterial culture media, where it ensures selective inhibition of Gram-negative bacteria. Molecular weight 582.5 g/mol: Ticarcillin Disodium with a molecular weight of 582.5 g/mol is used in molecular biology cloning experiments, where it provides accurate dosage control for antibiotic resistance screening. Sterility: Ticarcillin Disodium with verified sterility is used in sterile pharmaceutical formulations, where it prevents microbial contamination during drug preparation. pH 5.5–7.5: Ticarcillin Disodium with a pH range of 5.5–7.5 is used in cell culture applications, where it maintains optimal environmental conditions for mammalian cell viability. Solubility 100 mg/mL in water: Ticarcillin Disodium with a solubility of 100 mg/mL in water is used in injectable antibiotic solutions, where it enables rapid preparation and delivery of therapeutic doses. Stability at 4°C: Ticarcillin Disodium with stability at 4°C is used in long-term laboratory stock solutions, where it ensures consistent potency over extended storage periods. Low endotoxin level (<0.25 EU/mg): Ticarcillin Disodium with a low endotoxin level of less than 0.25 EU/mg is used in sensitive in vivo experiments, where it minimizes adverse immunogenic responses. Particle size <10 microns: Ticarcillin Disodium with particle size below 10 microns is used in intravenous formulations, where it ensures homogeneous suspension and prevents injection site irritation. Rapid dissolution rate: Ticarcillin Disodium with a rapid dissolution rate is used in emergency clinical settings, where it allows immediate antibiotic availability for acute infections. High assay potency (>950 μg/mg): Ticarcillin Disodium with an assay potency greater than 950 μg/mg is used in antibacterial susceptibility testing, where it delivers accurate determination of minimum inhibitory concentrations. |
Competitive Ticarcillin Disodium prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to sales3@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: sales3@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Standing at the intersection of microbiology and pharmaceutical synthesis, Ticarcillin Disodium demands consistent skill and purposeful effort on the part of the manufacturer. Years of refining production methods, investing in high-precision equipment, and upholding cleanroom standards underpin the powder’s reputation for purity and reliability. This work isn’t a marketing choice — it’s a necessity to achieve stable batch-to-batch quality and ensure that pharmaceutical partners and researchers get what they expect.
Ticarcillin Disodium occupies a practical place in both laboratory and clinical work. As a semi-synthetic penicillin, it serves as a versatile β-lactam antibiotic, effective against many strains of Gram-negative bacteria. This spectrum has direct implications in research, where contamination control can make or break an experiment. In finished pharmaceuticals, it empowers practitioners and patients to treat infections with precision, especially those that resist more basic penicillins.
Something often overlooked outside of manufacturing is the finesse needed to regulate the molar ratio between the ticarcillin molecule and disodium. Small shifts can invite impurities or reduce solubility, hurting both usability and stability. Our hands-on process control and analytical verification keep the ratio in the right window, helping avoid downstream complications — a lesson that’s come directly from years of troubleshooting and process optimization.
We offer Ticarcillin Disodium as a crystalline powder, white to off-white, targeting a model that balances purity and physical characteristics essential to its application. A practical minimum purity of 98.5% by HPLC isn’t just marketing — it comes from repeated input from researchers battling inconsistent results due to variance in antibiotic concentrations. This minimum purity provides reproducibility, letting users trust their own methods and results.
Moisture matters, too. Even a slight uptick in water content during shipping or storage can spoil an entire batch, so we tightly control water content, keeping it well below 5%. This extends shelf life and helps formulations remain stable longer. Particle size uniformity stems from our proprietary milling and sieving processes, which have been fine-tuned to match the dispersion needs of both research and pharmaceutical customers, preventing clumping or slow dissolution.
Our packaging — designed for laboratories, hospitals, and bulk processors — protects against light and moisture, addressing the exact weaknesses that degrade product quality over time. From kilo-packs used in compounding pharmacies to gram-level vials for research, each container passes visual and instrumental inspection to confirm its hermetic seal and integrity.
In the lab, Ticarcillin Disodium shines as a selective agent, often paired with clavulanic acid. Researchers rely on it to suppress unwanted microbes in cultures involving genetically modified bacteria. In our experience working with molecular biologists and agricultural scientists, maintaining consistency in antibiotic strength is crucial; unexpected drift can jeopardize entire research cycles or distort outcomes. Prepared in sterile aqueous solution, its high solubility streamlines workflow and reduces wait time for solution preparation.
Pharmaceutical compounding draws on the same consistency. Injectable forms must clear tough regulatory lines regarding sterility and particulate content. The process includes solution filtration, terminal sterilization, and aseptic transfer — all steps that can stress the molecule. Small changes in powder morphology and chemical stability can create headaches downstream, so feedback from pharmacists and clinicians has shaped ongoing improvements to our production line. Temperature- and moisture-controlled shipping underscores this commitment.
Veterinary customers, especially those treating equine or farm animal infections, have communicated unique volume and administration needs. High-volume packaging, certified for animal use, has seen refinements over the years in direct response to their insights about dosing and shelf-life requirements.
The chemical landscape overflows with generic antibiotics. Yet, differences emerge clearly upon close inspection and, most importantly, real-world use.
Manufacturers working only as traders or wholesalers will never see the details that come with firsthand production. Over years, we’ve realized that small deviations in raw ingredient sourcing can cascade through to finished product — trace solvent residues, batch-to-batch pH drift, and substandard lot segregation all add up. Our raw material procurement ties directly to sources with a proven record; incoming lots face spectroscopic and chromatographic analysis against verified standards.
Many generic suppliers claim compliance, yet ignore real-world implications of minor impurity profiles or beta-lactam ring stability. We’ve seen how these small impurities can cause non-obvious issues — loss of activity after reconstitution, unusual color changes, or even DNA-damaging reactive intermediates. Our analytics teams continually monitor not just known impurities, but also look for novel degradants uncovered during stress testing and aging studies.
Stability testing forms another cornerstone. Just because a certificate of analysis lists an “expiry date” doesn’t guarantee that a drug will perform to spec under unpredictable transit conditions. Our years of collaboration with international logistics teams taught us precisely which temperature and humidity excursions tend to erode product performance. We supplement accelerated stability testing with real-world storage simulation, measuring activity loss over months of ambient exposure, not just in idealized laboratory conditions.
Feedback from our clients has exposed subtle differences in how various Ticarcillin Disodium grades respond in buffered and unbuffered solutions, and how they perform when partnered with other antibiotics. Our R&D team modifies crystallization rates and buffer choices based on this, adding incremental stability and making end-use easier. Whether a customer injects, irrigates, or uses medium supplementation, our product holds up across use cases — because we’ve listened, documented issues, and acted.
We don’t view pharmacopoeia compliance as a finish line — it’s a minimum. Our team closely tracks global regulatory developments across the US, Europe, and China, ensuring our Ticarcillin Disodium meets or outpaces the latest purity, sterility, and labeling requirements. This means anticipating changes, not reacting after the fact. Our quality system relies on multi-stage batch record review and full traceability, so even years after release, we can track every lot to its source and production profile.
Choice of excipients and final bulk solution filtration parameters draw from hands-on experience, not just documentation. We maintain strict control over metal ion content, residual solvents, and known antibiotic degradants, repeatedly cross-referencing outcomes not just with pharmacopoeial chapters but also with real client feedback. If a compounder or researcher reports an anomaly, our batch retains and data loggers make root cause analysis practical, saving time and restoring confidence.
Responsible antibiotic manufacturing demands extra vigilance today. Drug-resistant bacteria spring up wherever antibiotics are misapplied or quality slips. Poorly made Ticarcillin can speed this problem, leaving patients and researchers with ineffective tools. From choosing fermentation strains for penicillin production with reliable yields, to synthesizing and purifying the final salt, we do not rush steps or swap shortcuts for dollars.
We take active steps in educating our staff and downstream users about the risks of antibiotic misuse. That means providing deep-dive explanations to customers looking to streamline dosing or explore new research fields, without sacrificing potency or stability. In parallel, we work with transportation and warehousing partners to track cold-chain breaks in real time and intervene early — a safeguard that’s become even more important as global temperatures fluctuate and logistics chains become exposed to wider variation.
The real edge comes from relentless process improvement. Decades in penicillin and semi-synthetic antibiotic synthesis have taught us that no batch is truly routine. Every lot provides new data — sometimes subtle, sometimes urgent. Statistical process controls, spectroscopy, water activity meters, and record management platforms help us spot micro-trends before they become headaches.
In-house R&D doesn’t just test incremental production tweaks but explores ways to enhance the molecule’s stability, solubility, and compatibility with next-generation delivery systems. For example, some innovations in particle engineering let us reduce aggregation issues in concentrated solutions used for certain research protocols, and ongoing work in green chemistry points toward less waste-intensive purification steps.
This commitment couples closely with knowledge sharing. Industry conferences, technical customer meetings, and ongoing dialogue with regulatory authorities help us understand where Ticarcillin Disodium will be needed tomorrow. Every insight — whether from a regulatory inspection or a field technician — folds back into our practice, closing the loop between intention and implementation.
The substance we ship leaves our doors with a clear purpose. Researchers count on it to power discovery in labs, while clinicians use it to treat patients who may have exhausted other options. Stories of successful genetic engineering runs or prompt clinical recoveries are more than anecdotes for us — they are proof that precision, care, and experience at the manufacturing end have downstream value.
Many of our best improvements spring from direct conversation. We’ve worked with university researchers frustrated by contaminated growth media, adjusted our processes after hearing from hospital pharmacists about solubility quirks, and introduced new vial formats for veterinary clinics dealing with unique administration protocols. Rather than offering a “one size fits all” approach, we treat each feedback loop as a chance to evolve and cement our place as a trusted partner, not a faceless supplier.
Ticarcillin Disodium isn’t the only β-lactam in the market, but it outperforms options like Carbenicillin or Piperacillin in certain respects for research and therapy. Carbenicillin, while popularized in earlier molecular biology protocols, struggles with stability after reconstitution — a problem for labs that prepare stock solutions for longer storage. Ticarcillin, on the other hand, demonstrates greater resistance to degradation and less spontaneous decarboxylation, leading to more predictable results over time.
Comparing to Piperacillin Disodium, Ticarcillin sacrifices some spectrum against certain tough pathogens but delivers more targeted Gram-negative coverage suited for lab protocols, minimizing off-target effects. In pharmaceutical compounding, Ticarcillin’s slightly lower propensity for allergic cross-reactivity makes it a preferred option in specific clinical cases, a fact underlined by direct feedback from infectious disease specialists.
Another point of distinction centers on endotoxin content. Endotoxin contamination has plagued many third-party producers, especially those diluting compliance or skipping filtration steps to save time. We strictly control this risk, using validated depyrogenation protocols and confirming every batch meets injectable standards — something research and clinical customers both rely on for reproducible safety.
Changing science and medicine continues to stress-test established practices. With growing interest in antibiotic stewardship, gene editing, and synthetic biology, the requirements for core compounds like Ticarcillin Disodium are in constant motion. Instead of waiting for demand to clarify, we take a proactive role by supporting investigative work, providing technical validation, and refining products based on what’s happening at the front lines.
A challenge often cited is the wave of environmental scrutiny on pharmaceutical waste. Legacy production methods can leave unwanted residues and byproducts, enough to create headaches for those concerned about green chemistry. Well before regulatory mandates, we overhauled key process steps to recover solvents, minimize water use, and downgrade the toxicity profile of all waste streams. This improvement came not from abstract goals, but from real feedback about supply chain responsibility — and the recognition that sustainable sourcing now matters as much as baseline product quality.
Our story with Ticarcillin Disodium doesn’t begin and end in the laboratory or on the pharmacy shelf. The work at each stage, from careful raw material selection to batch release, draws from years of accumulated experience, advances in equipment, and daily lessons learned alongside our partners. By staying curious, transparent, and grounded in the practical realities of production, we keep refining not just products, but the relationships that make innovation possible.
Years from now, Ticarcillin Disodium will continue shaping everything from agricultural research to front-line healthcare, but the real progress comes from listening and acting — from small improvements in a manufacturing step to big shifts in how antibiotics help people and science. For any organization building new antibiotics, formulating critical medications, or investigating genetic techniques, we aim to supply more than just a powder. We offer knowledge, reliability, and the ongoing commitment to quality that only an experienced manufacturer can provide.